Lessons Learned, Challenges, and Opportunities: The US Endocrine Disruptor Screening Program
Date: April 23-24, 2013
Location: North Carolina Biotechnology Center, Research Triangle Park, North Carolina
Meeting Program (Includes speaker bios and abstracts)
The Endocrine Disruptor Screening Program (EDSP) was implemented by the US Environmental Protection Agency (EPA) by issuing the first round of test orders in 2009 for information on 67 chemicals (59 pesticide active ingredients and 8 pesticide inert ingredients). The request includes information from a battery of screening assays, referred to as Tier 1, includes five in vitro assays, four mammalian assays, and two non-mammalian assays. Tier 1 screening of this initial list of chemicals has now been completed and the data have been submitted to EPA. This screening has yielded large volumes of data derived from numerous laboratories and on a variety of chemical classes.
A FORUM TO SHARE EXPERIENCE AND INSIGHTS
The results from this first phase of testing represent the first comprehensive experience with these assays individually and as a battery in a regulatory context. The experience and insight of the practitioners and laboratories conducting the screening provides an unprecedented resource for informing the future success of the program.
This workshop brings together multiple stakeholders for the opportunity to review and discuss the challenges and lessons learned from the initial experiences with Tier 1 screening assays in an open forum. Such an open meeting with all stakeholders – including Federal Regulatory Agencies, NGOs, industry, contract laboratory scientists, and academic researchers - is critical - and timely - to best use this collective experience for potential improvements in Tier 1 assays, and to further advance our ability to assess endocrine disruption. All stakeholders and interested parties are invited to participate.
This open workshop is designed to focus on the science and experience to date and is not intended to be a forum to discuss individual chemicals and their performance in the Tier 1 screening assays. Lessons learned and the ensuing discussion/outcomes at this workshop will support the use and implementation of the proposed advancements described in the EDSP21 (Endocrine Disruptor Screening Program – 21st Century) and TT21C (Toxicity Testing in the 21st Century) visions.
For more information, contact Jacqueline Patterson (email@example.com or 513-542-7475)